Protein tyrosine phosphatase PTPN3 inhibits lung cancer cell proliferation and migration by promoting EGFR endocytic degradation

Oncogene

Volumn 34, Issue 29, 2015, Pages 3791-3803

  Li, M Y ^a,b   Lai, P L ^a   Chou, Y T ^c   Chi, A P ^a   Mi, Y Z ^a   Khoo, K H ^a,b   Chang, G D ^b   Wu, C W ^c   Meng, T C ^a,b   Chen, G C ^a,b  

^a INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR PATHWAY SUBSTRATE 15; LENTIVIRUS VECTOR; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 3; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 4; SHORT HAIRPIN RNA; EPS15 PROTEIN, HUMAN; PTPN3 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER INHIBITION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG TARGETING; ENDOCYTOSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIPID RAFT; LUNG CANCER CELL LINE; LYSOSOME; MACROPHAGE MIGRATION INHIBITION; MALE; MOUSE; MUTANT; NON SMALL CELL LUNG CANCER; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPHOSPHORYLATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; VIRAL GENE DELIVERY SYSTEM; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; CELL MEMBRANE; CELL MOTION; CONFOCAL MICROSCOPY; FEMALE; GENETICS; HEK293 CELL LINE; IMMUNOBLOTTING; LUNG TUMOR; METABOLISM; MUTATION; NUDE MOUSE; PATHOLOGY; PHOSPHORYLATION; RNA INTERFERENCE; TRANSGENIC ANIMAL; TUMOR CELL LINE; XENOGRAFT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANIMALS, GENETICALLY MODIFIED; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; ENDOCYTOSIS; FEMALE; HEK293 CELLS; HUMANS; IMMUNOBLOTTING; LUNG NEOPLASMS; MALE; MEMBRANE MICRODOMAINS; MICE, INBRED BALB C; MICE, NUDE; MICROSCOPY, CONFOCAL; MUTATION; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 3; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA INTERFERENCE; TRANSPLANTATION, HETEROLOGOUS;

EID: 84937398471     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.312     Document Type: Article

References (59)

1. Tonks NK. Protein tyrosine phosphatases: from genes, to function, to disease. Nat Rev Mol Cell Biol 2006; 7: 833-846.
2. Hunter T. Tyrosine phosphorylation: thirty years and counting. Curr Opin Cell Biol 2009; 21: 140-146.
3. Bogdan S, Klambt C. Epidermal growth factor receptor signaling. Curr Biol 2001; 11: R292-R295.
4. Citri A, Yarden Y. EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol 2006; 7: 505-516.
5. Sorkin A, Goh LK. Endocytosis and intracellular trafficking of ErbBs. Exp Cell Res 2009; 315: 683-696.
6. Sebastian S, Settleman J, Reshkin SJ, Azzariti A, Bellizzi A, Paradiso A. The complexity of targeting EGFR signalling in cancer: from expression to turnover. Biochim Biophysic Acta 2006; 1766: 120-139.
7. Tarcic G, Boguslavsky SK, Wakim J, Kiuchi T, Liu A, Reinitz F et al. An unbiased screen identifies DEP-1 tumor suppressor as a phosphatase controlling EGFR endocytosis. Curr Biol 2009; 19: 1788-1798.
8. Yuan T, Wang Y, Zhao ZJ, Gu H. Protein-tyrosine phosphatase PTPN9 negatively regulates ErbB2 and epidermal growth factor receptor signaling in breast cancer cells. J Biol Chem 2010; 285: 14861-14870.
9. Xu Y, Tan LJ, Grachtchouk V, Voorhees JJ, Fisher GJ. Receptor-type protein-tyrosine phosphatase-kappa regulates epidermal growth factor receptor function. J Biol Chem 2005; 280: 42694-42700.
10. Tiganis T. Protein tyrosine phosphatases: dephosphorylating the epidermal growth factor receptor. IUBMB Life 2002; 53: 3-14.
11. Sun T, Aceto N, Meerbrey KL, Kessler JD, Zhou C, Migliaccio I et al. Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase. Cell 2011; 144: 703-718.
12. Eden ER, White IJ, Futter CE. Down-regulation of epidermal growth factor receptor signalling within multivesicular bodies. Biochem Soc Trans 2009; 37(Pt 1): 173-177.
13. Tonks NK. PTP1B: from the sidelines to the front lines! FEBS Lett 2003; 546: 140-148.
14. Eden ER, White IJ, Tsapara A, Futter CE. Membrane contacts between endosomes and ER provide sites for PTP1B-epidermal growth factor receptor interaction. Nat Cell Biol 2010; 12: 267-272.
15. Woodman P. ESCRT proteins, endosome organization and mitogenic receptor down-regulation. Biochem Soc Trans 2009; 37(Pt 1): 146-150.
16. Ali N, Zhang L, Taylor S, Mironov A, Urbe S, Woodman P. Recruitment of UBPY and ESCRT exchange drive HD-PTP-dependent sorting of EGFR to the MVB. Curr Biol 2013; 23: 453-461.
17. Zhang SH, Liu J, Kobayashi R, Tonks NK. Identification of the cell cycle regulator VCP (p97/CDC48) as a substrate of the band 4.1-related protein-tyrosine phosphatase PTPH1. J Biol Chem 1999; 274: 17806-17812.
18. Gu M, Meng K, Majerus PW. The effect of overexpression of the protein tyrosine phosphatase PTPMEG on cell growth and on colony formation in soft agar in COS-7 cells. Proc Natl Acad Sci USA 1996; 93: 12980-12985.
19. Whited JL, Robichaux MB, Yang JC, Garrity PA. Ptpmeg is required for the proper establishment and maintenance of axon projections in the central brain of Drosophila. Development 2007; 134: 43-53.
20. van Bergen En Henegouwen PM. Eps15: a multifunctional adaptor protein regulating intracellular trafficking. Cell Commun Signal 2009; 7: 24.
21. Chen DY, Li MY, Wu SY, Lin YL, Tsai SP, Lai PL et al. The Bro1-domain-containing protein Myopic/HDPTP coordinates with Rab4 to regulate cell adhesion and migration. J Cell Sci 2012; 125(Pt 20): 4841-4852.
22. Duchek P, Somogyi K, Jekely G, Beccari S, Rorth P. Guidance of cell migration by the Drosophila PDGF/VEGF receptor. Cell 2001; 107: 17-26.
23. Duchek P, Rorth P. Guidance of cell migration by EGF receptor signaling during Drosophila oogenesis. Science 2001; 291: 131-133.
24. Martin-Blanco E, Roch F, Noll E, Baonza A, Duffy JB, Perrimon N. A temporal switch in DER signaling controls the specification and differentiation of veins and interveins in the Drosophila wing. Development 1999; 126: 5739-5747.
25. Shilo BZ. Signaling by the Drosophila epidermal growth factor receptor pathway during development. Exp Cell Res 2003; 284: 140-149.
26. Ku HY, Wu CL, Rabinow L, Chen GC, Meng TC. Organization of F-actin via concerted regulation of Kette by PTP61F and dAbl. Mol Cell Biol 2009; 29: 3623-3632.
27. Gabay L, Seger R, Shilo BZ. In situ activation pattern of Drosophila EGF receptor pathway during development. Science 1997; 277: 1103-1106.
28. Pignoni F, Zipursky SL. Induction of Drosophila eye development by decapentaplegic. Development 1997; 124: 271-278.
29. Fazioli F, Minichiello L, Matoskova B, Wong WT, Di Fiore PP. eps15, a novel tyrosine kinase substrate, exhibits transforming activity. Mol Cell Biol 1993; 13: 5814-5828.
30. Hironaka K, Umemori H, Tezuka T, Mishina M, Yamamoto T. The protein-tyrosine phosphatase PTPMEG interacts with glutamate receptor delta 2 and epsilon subunits. J Biol Chem 2000; 275: 16167-16173.
31. Kina S, Tezuka T, Kusakawa S, Kishimoto Y, Kakizawa S, Hashimoto K et al. Involvement of protein-tyrosine phosphatase PTPMEG in motor learning and cerebellar long-term depression. Eur J Neurosci 2007; 26: 2269-2278.
32. Labbe DP, Hardy S, Tremblay ML. Protein tyrosine phosphatases in cancer: friends and foes!. Prog Mol Biol Transl Sci 2012; 106: 253-306.
33. Confalonieri S, Salcini AE, Puri C, Tacchetti C, Di Fiore PP. Tyrosine phosphorylation of Eps15 is required for ligand-regulated, but not constitutive, endocytosis. J Cell Biol 2000; 150: 905-912.
34. Grandal MV, Madshus IH. Epidermal growth factor receptor and cancer: control of oncogenic signalling by endocytosis. J Cell Mol Med 2008; 12: 1527-1534.
35. Parachoniak CA, Park M. Distinct recruitment of Eps15 via Its coiled-coil domain is required for efficient down-regulation of the met receptor tyrosine kinase. J Biol Chem 2009; 284: 8382-8394.
36. Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF. Met, metastasis, motility and more. Nat Rev Mol Cell Biol 2003; 4: 915-925.
37. Gherardi E, Birchmeier W, Birchmeier C, Vande Woude G. Targeting MET in cancer: rationale and progress. Nat Rev Cancer 2012; 12: 89-103.
38. Sigismund S, Woelk T, Puri C, Maspero E, Tacchetti C, Transidico P et al. Clathrinindependent endocytosis of ubiquitinated cargos. Proc Natl Acad Sci USA 2005; 102: 2760-2765.
39. Sigismund S, Argenzio E, Tosoni D, Cavallaro E, Polo S, Di Fiore PP. Clathrinmediated internalization is essential for sustained EGFR signaling but dispensable for degradation. Dev Cell 2008; 15: 209-219.
40. Benmerah A, Bayrou M, Cerf-Bensussan N, Dautry-Varsat A. Inhibition of clathrincoated pit assembly by an Eps15 mutant. J Cell Sci 1999; 112(Pt 9): 1303-1311.
41. Orlandi PA, Fishman PH. Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domains. J Cell Biol 1998; 141: 905-915.
42. Parpal S, Karlsson M, Thorn H, Stralfors P. Cholesterol depletion disrupts caveolae and insulin receptor signaling for metabolic control via insulin receptor substrate- 1, but not for mitogen-activated protein kinase control. J Biol Chem 2001; 276: 9670-9678.
43. Sharma SV, Bell DW, Settleman J, Haber DA. Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer 2007; 7: 169-181.
44. Nomura M, Shigematsu H, Li L, Suzuki M, Takahashi T, Estess P et al. Polymorphisms, mutations, and amplification of the EGFR gene in non-small cell lung cancers. PLoS Med 2007; 4: e125.
45. Jung Y, Kim P, Keum J, Kim SN, Choi YS, Do IG et al. Discovery of ALK-PTPN3 gene fusion from human non-small cell lung carcinoma cell line using next generation RNA sequencing. Genes Chromosomes Cancer 2012; 51: 590-597.
46. Sibilia M, Kroismayr R, Lichtenberger BM, Natarajan A, Hecking M, Holcmann M. The epidermal growth factor receptor: from development to tumorigenesis. Differentiation 2007; 75: 770-787.
47. Chi S, Cao H, Chen J, McNiven MA. Eps15 mediates vesicle trafficking from the trans-Golgi network via an interaction with the clathrin adaptor AP-1. Mol Biol Cell 2008; 19: 3564-3575.
48. Di Guglielmo GM, Le Roy C, Goodfellow AF, Wrana JL. Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover. Nat Cell Biol 2003; 5: 410-421.
49. Bonifacino JS, Traub LM. Signals for sorting of transmembrane proteins to endosomes and lysosomes. Annu Rev Biochem 2003; 72: 395-447.
50. Huang F, Goh LK, Sorkin A. EGF receptor ubiquitination is not necessary for its internalization. Proc Natl Acad Sci USA 2007; 104: 16904-16909.
51. Roxrud I, Raiborg C, Pedersen NM, Stang E, Stenmark H. An endosomally localized isoform of Eps15 interacts with Hrs to mediate degradation of epidermal growth factor receptor. J Cell Biol 2008; 180: 1205-1218.
52. Lessard L, Stuible M, Tremblay ML. The two faces of PTP1B in cancer. Biochim Biophysica Acta 2010; 1804: 613-619.
53. Wu CW, Chen JH, Kao HL, Li AF, Lai CH, Chi CW et al. PTPN3 and PTPN4 tyrosine phosphatase expression in human gastric adenocarcinoma. Anticancer Res 2006; 26: 1643-1649.
54. Hou SW, Zhi HY, Pohl N, Loesch M, Qi XM, Li RS et al. PTPH1 dephosphorylates and cooperates with p38gamma MAPK to increase ras oncogenesis through PDZmediated interaction. Cancer Res 2010; 70: 2901-2910.
55. Zhi HY, Hou SW, Li RS, Basir Z, Xiang Q, Szabo A et al. PTPH1 cooperates with vitamin D receptor to stimulate breast cancer growth through their mutual stabilization. Oncogene 2011; 30: 1706-1715.
56. Wang Z, Shen D, Parsons DW, Bardelli A, Sager J, Szabo S et al. Mutational analysis of the tyrosine phosphatome in colorectal cancers. Science 2004; 304: 1164-1166.
57. Hong CF, Chou YT, Lin YS, Wu CW. MAD2B, a novel TCF4-binding protein, modulates TCF4-mediated epithelial-mesenchymal transdifferentiation. J Biol Chem 2009; 284: 19613-19622.
58. Hawash IY, Kesavan KP, Magee AI, Geahlen RL, Harrison ML. The Lck SH3 domain negatively regulates localization to lipid rafts through an interaction with c-Cbl. J Biol Chem 2002; 277: 5683-5691.
59. Chou YT, Lin HH, Lien YC, Wang YH, Hong CF, Kao YR et al. EGFR promotes lung tumorigenesis by activating MIR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF. Cancer Res 2010; 70: 8822-8831.